NCT03255837

Brief Summary

This study will involve an experiment in individuals with Autism Spectrum Disorder (ASD) comparing their performance on a working memory task before, during and after non-invasive brain stimulation (tDCS) compared to a control group in a 3x3 factorial design. How the stimulation affects performance on the task will be assessed, along with the impact of the intervention on the individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 21, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

February 26, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2018

Completed
Last Updated

January 25, 2019

Status Verified

January 1, 2019

Enrollment Period

10 months

First QC Date

August 16, 2017

Last Update Submit

January 23, 2019

Conditions

Keywords

Transcranial StimulationMemory

Outcome Measures

Primary Outcomes (1)

  • Working memory accuracy score compared to typically developed controls scores.

    Result of N-back memory task

    Change from baseline (before stimulation) to after stimulation (1 week)

Secondary Outcomes (2)

  • Difference in working memory accuracy score between adults with ASD and healthy controls

    Before stimulation

  • Difference in working memory accuracy score between adults with ASD and healthy controls

    After stimulation (1 week)

Study Arms (3)

Transcranial direct current stimulation (tDCS) - anodal

EXPERIMENTAL

Transcranial direct current stimulation - anodal (positive) 1.5 millamps for 15 minutes

Device: Transcranial direct current stimulation (tDCS)

Transcranial direct current stimulation (tDCS) - cathodal

EXPERIMENTAL

Transcranial direct current stimulation - cathodal (negative) 1.5 millamps for 15 minutes

Device: Transcranial direct current stimulation (tDCS)

Transcranial direct current stimulation (tDCS) - sham

SHAM COMPARATOR

Transcranial direct current stimulation - sham session 15 minutes

Device: Transcranial direct current stimulation (tDCS)

Interventions

Transcranial Direct Current Stimulation (tDCS, a form of non-invasive brain stimulation) on the left dorsolateral prefrontal cortex (DLPFC)

Transcranial direct current stimulation (tDCS) - anodalTranscranial direct current stimulation (tDCS) - cathodalTranscranial direct current stimulation (tDCS) - sham

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • clinical diagnosis of ASD
  • right handed
  • speaks English fluently
  • normal vision or corrected to normal
  • passing tDCS safety screening

You may not qualify if:

  • participants who do not understand verbal or written English (i.e would be in need of translators)
  • participants that have ever suffered from epilepsy, febrile convulsions in infancy or had recurrent fainting spells
  • family history of epilepsy
  • has a heart pacemaker, cochlear implant, medication pump, surgical clips
  • has drunk more than 3 units of alcohol in the last 24 hours
  • suffers from migraines
  • metal in the head, implanted brain medical devices
  • has undergone a neurosurgical procedure
  • has had more than one cup of coffee, or other sources of caffeine in the last hour
  • taking any unprescribed or prescribed medication that might effect tDCS
  • medications or psychoactive drugs that can lower seizure threshold \[imipramine, amitriptyline, doxepine, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, cocaine, (MDMA, ecstasy), phencyclidine (PCP, angel dust), ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline\]
  • withdrawal from alcohol, barbiturates, benzodiazepines, meprobamate, chloral hydrate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Glasgow

Glasgow, United Kingdom

Location

MeSH Terms

Conditions

Autism Spectrum Disorder

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Craig Melville, MD

    University of Glasgo

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be unaware of the order in which they receive the transcranial stimulation condition (anodal, cathodal, sham).
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Each participant will receive the same 3 kinds of transcranial stimulation. However, the order in which they receive them will be randomly allocated.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2017

First Posted

August 21, 2017

Study Start

February 26, 2018

Primary Completion

December 21, 2018

Study Completion

December 21, 2018

Last Updated

January 25, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations